Allspring Global Investments Holdings, LLC Allogene Therapeutics, Inc. Transaction History

Allspring Global Investments Holdings, LLC

  • $62.1 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 23, 2023
SELL
$5.62 - $11.11 $393 - $777
-70 Reduced 2.17%
3,158 $0
Q3 2022

Oct 26, 2022
BUY
$10.32 - $17.28 $33,312 - $55,779
3,228 New
3,228 $34,000
Q2 2022

Jul 25, 2022
SELL
$6.78 - $12.28 $16,373 - $29,656
-2,415 Closed
0 $0
Q1 2022

May 02, 2022
SELL
$7.65 - $15.29 $1,025 - $2,048
-134 Reduced 5.26%
2,415 $22,000
Q4 2021

Jan 28, 2022
BUY
$13.13 - $24.52 $33,468 - $62,501
2,549 New
2,549 $38,000

Others Institutions Holding ALLO

# of Institutions
162
Shares Held
134M
Call Options Held
59.4K
Put Options Held
113K
View Full List

About Allogene Therapeutics, Inc.

ALLO Quotes by TradingView
  • Ticker ALLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 143,807,008
  • Market Cap $326M
  • Description
  • Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...
More about ALLO
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email